Table 1.
Patient demographics and clinical characteristics at initial consult and first follow up.
| Initial Consult (n=375) | Follow Up (n=275) | p-value* | ||
|---|---|---|---|---|
| Age | Mean ± Std | 55.6 ± 13.1 | 56.3 ± 12.4 | 0.18 |
| Median (Min, Max) | 57.0 (8.0, 88.0) | 57.0 (8.0, 88.0) | ||
| Gender | Female | 256 (68.3%) | 191 (69.5%) | 0.41 |
| Male | 119 (31.7%) | 84 (30.5%) | ||
| Race | White/Caucasian | 277 (73.9%) | 205 (74.5%) | 0.45 |
| Hispanic/Latino | 42 (11.2%) | 32 (11.6%) | ||
| Black/African American | 22 (5.9%) | 13 (4.7%) | ||
| Asian | 20 (5.3%) | 16 (5.8%) | ||
| Other | 6 (1.6%) | 3 (1.1%) | ||
| Unknown | 8 (2.1%) | 6 (2.2%) | ||
| Marital Status | Married/Significant Other | 285 (76.0%) | 218 (79.3%) | 0.035 |
| Single | 46 (12.3%) | 29 (10.5%) | ||
| Divorced | 32 (8.5%) | 18 (6.5%) | ||
| Widowed | 9 (2.4%) | 8 (2.9%) | ||
| Unknown | 3 (0.8%) | 2 (0.7%) | ||
| Residency | Harris County | 133 (35.5%) | 114 (41.5%) | <0.001 |
| Seven Surrounding Counties | 53 (14.1%) | 39 (14.2%) | ||
| Rest of Texas | 65 (17.3%) | 40 (14.5%) | ||
| Rest of US | 106 (28.3%) | 71 (25.8%) | ||
| International | 18 (4.8%) | 11 (4.0%) | ||
| Cancer Type | Breast | 123 (32.8%) | 92 (33.5%) | 0.32 |
| Thoracic/Head and Neck | 97 (25.9%) | 72 (26.2%) | ||
| Gastrointestinal | 57 (15.2%) | 37 (13.5%) | ||
| Lymphoma/Myeloma | 33 (8.8%) | 21 (7.6%) | ||
| Genitourinary | 24 (6.4%) | 18 (6.5%) | ||
| Gynecologic | 17 (4.5%) | 14 (5.1%) | ||
| Leukemia | 9 (2.4%) | 7 (2.6%) | ||
| No evidence of disease | 6 (1.6%) | 6 (2.2%) | ||
| Skin | 5 (1.3%) | 4 (1.5%) | ||
| Other | 4 (1.1%) | 4 (1.5%) | ||
| Number of treatments | Mean ± Std | 4.61 ± 5.12 | ||
| Median (Min, Max) | 3.0 (1.0, 48.0) | |||
| Days to 1st follow-up | Mean ± Std | 10.06 ± 20.34 | ||
| Median (Min, Max) | 5.0 (1.0, 193.0) | |||
*Represents comparison between those did not follow up (n=100) and those with at least one follow up (n=275). Significant difference is represented in bold.